Intrinsic Value of S&P & Nasdaq Contact Us

Zoetis Inc. ZTS NYSE

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
71/100
4/7 Pass
SharesGrow Intrinsic Value
$130.84
+8%
Analyst Price Target
$143.86
+18.8%

Stock Statistics — ZTS

Zoetis Inc. (ZTS) has a market capitalization of $51.12B and trades at $121.11. The 52-week range is 113.29-172.23.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 20.1, Earnings Per Share (EPS) of $6.03, annual revenue of $9.47B.

The stock has a beta of 0.97, a last dividend of $2.0300, operates in the Healthcare sector.

Trading Data
Current Price$121.11
52-Week Range113.29-172.23
Volume1.97M
Avg Volume (30D)4.27M
Market Cap$51.12B
Beta (1Y)0.97
Last Dividend$2.0300
Company
IPO Date2013-02-01
Employees13,800
CEOKristin C. Peck
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS98978V1035
CUSIP98978V103
Income (Latest Year)
Revenue$9.47B
Gross Profit$6.67B
EBITDA$4.07B
Operating Income$3.6B
Net Income$2.67B
EPS$6.03
EPS Diluted$6.02
Shares Outstanding$443.44M
Balance Sheet (Latest Year)
Total Assets$15.47B
Current Assets$6.77B
Cash & ST Investments$2.31B
Total Liabilities$12.14B
Total Debt$9.49B
Net Debt$7.18B
Total Equity$3.33B
Debt / Equity2.85
Valuation Ratios
P/E Ratio20.1
P/S Ratio5.4
P/B Ratio15.35
EV/EBITDA (approx)12.6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message